【レポートの概要(一部)】
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 8
2 Pharmaceuticals & Healthcare, Global, Deal Summary 12
2.1 Pharmaceuticals & Healthcare, Global, Deal Analysis, October 2013 12
2.2 Pharmaceuticals & Healthcare, Global, Major Deals, October 2013 14
2.2.1 McKesson to Acquire Celesio for US$8.3 Billion 14
2.2.2 Bristol-Myers Squibb Completes Public Offering of Notes for US$1.5 Billion 16
2.2.3 Ventas Acquires Portfolio of Independent Living Communities from Holiday Retirement for US$790 Million 16
2.2.4 BioMarin Pharma Completes Public Offering of Notes for US$750 Million 16
2.2.5 Astellas Pharma Enters Into R&D Agreement with Mitokyne for Drug Discovery 17
2.3 Pharmaceuticals & Healthcare, Global, by Type, Number of Deals, October 2013 18
2.4 Pharmaceuticals & Healthcare, Global, by Type, Deal Values, October 2013 19
3 Pharmaceuticals and Healthcare, Global, Deals, Summary, by Type 20
3.1 Pharmaceuticals & Healthcare, Global, M&A, October 2013 20
3.1.1 Top M&A Deals in October 2013 21
3.1.2 Pharmaceuticals & Healthcare, Global, M&A Deals by Therapy Area, May 2013 – October 2013 22
3.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals, October 2013 23
3.2.1 Top Equity Offering Deals in October 2013 24
3.2.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals by Therapy Area, May 2013 – October 2013 25
3.3 Pharmaceuticals & Healthcare, Global, Private Equity and Venture Capital Deals, October 2013 27
3.3.1 Top PE/VC Deals in October 2013 28
3.3.2 Pharmaceuticals & Healthcare, Global, PE/VC by Therapy Area, October 2013 29
3.3.3 Pharmaceuticals & Healthcare, Global, Venture Capital Deals by Stage of Financing, October 2013 31
3.3.4 Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, May 2013-October 2013 33
3.3.5 Pharmaceuticals & Healthcare, Global, Top VC Backed Companies, May 2013-October 2013 34
4 Pharmaceuticals & Healthcare, Global, Partnership Deals, October 2013 35
4.1 Pharmaceuticals & Healthcare, Global, Partnership Deals, October 2013 35
4.2 Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, May 2013 – October 2013 37
4.3 Pharmaceuticals & Healthcare, Global, Partnership Deals by Upfront and Milestone Payments and Deal Values (US$ m), October 2013 39
4.3.1 Pharmaceuticals & Healthcare, Global, Top Partnership Deals by Payment Mode, October 2013 41
4.4 Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, by Upfront and Milestone Payments and Deal Values (US$ m), May 2013 – October 2013 42
4.5 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, Number Of Deals, May 2013 – October 2013 44
4.6 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, Deal Values (US$ m), May 2013 – October 2013 45
4.7 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, by Upfront & Milestone Payments and Deal Values (US$ m), May 2013 – October 2013 47
5 Pharmaceuticals & Healthcare, Global, Licensing Agreements, October 2013 49
5.1 Pharmaceuticals & Healthcare, Global, Licensing Agreements, October 2013 49
5.2 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Upfront and Milestone Payments and Deal Values (US$ m), October 2013 51
5.2.1 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements by Deal Value, October 2013 53
5.2.2 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Total Upfront Payments, October 2013 53
5.2.3 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements by Total Milestone Payment, October 2013 54
5.3 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Total Deal Values (US$ m), May 2013 – October 2013 55
5.4 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Upfront Payments and Milestone Payments (US$ m), May 2013 – October 2013 57
5.5 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Total Deal Values (US$ m), May 2013 – October 2013 59
5.6 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Upfront Payments and Milestone Payments (US$ m), May 2013 – October 2013 61
6 Pharmaceuticals & Healthcare, Global, Deal Summary by Therapy Area 63
6.1 Pharmaceuticals & Healthcare, Global, Oncology Deals, October 2013 63
6.1.1 Oncology – Deals of the Month 65
6.2 Pharmaceuticals & Healthcare, Global, Central Nervous System Deals, October 2013 67
6.2.1 Central Nervous System – Deals of the Month 69
6.3 Pharmaceuticals & Healthcare, Global, Immunology Deals, October 2013 70
6.3.1 Immunology – Dealsof the Month 72
6.4 Pharmaceuticals & Healthcare, Global, Infectious Disease Deals, October 2013 73
6.4.1 Infectious Diseases – Deals of the Month 75
6.5 Pharmaceuticals & Healthcare, Global, Metabolic Disorder Deals, October 2013 76
6.5.1 Metabolic Disorders – Deal of the Month 78
6.6 Pharmaceuticals & Healthcare, Global, Cardiovascular Deals, October 2013 81
6.6.1 Cardiovascular – Deal of the Month 82
6.7 Pharmaceuticals & Healthcare, Global, Hematological Disorders, Deals, October 2013 84
6.7.1 Hematological Disorders – Deal of the Month 85
7 Deal Summary by Geography 87
7.1 Pharmaceuticals & Healthcare, North America Deals, October 2013 87
7.1.1 North America – Deals of the Month 89
7.2 Pharmaceuticals & Healthcare, Europe, Deals, October 2013 91
7.2.1 Europe – Deals of the Month 92
7.3 Pharmaceuticals & Healthcare, Asia-Pacific, Regional Deals, October 2013 94
7.3.1 Asia-Pacific – Deals of the Month 96
7.4 Pharmaceuticals & Healthcare, Rest of the World, Deals, October 2013 97
7.4.1 Rest of the World – Deals of the Month 99
8 Pharmaceuticals & Healthcare, Global, Top Financial Advisors 100
8.1 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, M&A, May 2013 – October 2013 100
8.2 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, Equity Offerings, May 2013 – October 2013 102
9 Further Information 104
9.1 Methodology 104
9.2 About GlobalData 105
9.3 Disclosure information 106
9.4 Disclaimer 106
【レポート販売概要】
■ タイトル:Pharmaceuticals Monthly Deals Analysis: October 2013 – Partnerships, Licensing, Investments and M&A Trends■ 英文:Pharmaceuticals Monthly Deals Analysis: October 2013 - Partnerships, Licensing, Investments and M&A Trends
■ 発行日:2013年11月30日
■ 調査会社:GlobalData
■ 商品コード:GDATA403162982
■ 調査対象地域:グローバル
- 無水酢酸の世界市場:酢酸セルロース、医薬品、TAED、PTMEG用途About Acetic Anhydride Acetic Anhydride, also known as ethanoic anhydride, is the simplest isolatable acid anhydride, produced from acetic acid. It has strong lachrymatory properties and finds usage in the manufacture of cellulose acetate, a commercially important chemical used in the production of cellulose acetate flakes and cellulose acetate plastics. Acetic anhydride is colorless, highly water …
- PetroChina Company Limited:石油・ガスの開発・生産動向及びコスト分析- Q1, 2013PetroChina Company Limited Oil & Gas Exploration and Production Operations and Cost Analysis - Q1, 2013 Summary PetroChina Company Limited Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essent …
- がん栄養学の世界市場:がんのタイプ別(頭頸部がん、胃がん・消化器がん、肝臓がん、膵臓がん、食道がん、肺がん、乳がん、血液がん)、地域別予測Global Oncology nutrition Market to reach USD 2.80 billion by 2025. Global Oncology nutrition Market valued approximately USD 1.3 billion in 2016 is anticipated to grow with a healthy growth rate of more than 9% over the forecast period 2017-2025. The overall growth of the market is largely driven by the shifting focus from parenteral to enteral nutrition, increasing incidence of cancer, growing d …
- ポリブチレンテレフタレート(PBT)の世界市場2016-2020About Polybutylene Terephthalate PBT is a saturated polyester that is mainly obtained from butanediol (BDO) and terephthalic acid or dimethyl terephthalate (DMT). It is extensively used in the polymers and plastics industry because it offers high-performance blends like polyethylene terephthalate (PET), acrylonitrile styrene acrylate (ASA), and others. PBT offers a valuable combination of high tec …
- 風力タービン用鋳造品の世界市場分析:タイプ別(水平軸、垂直軸)、用途別(オンショア、オフショア)、地域別(北アメリカ、ヨーロッパ、アジア太平洋、中南米、MEA)、セグメント予測、2014-2025The global wind turbine casting market is expected to reach USD 3.27 billion by 2025, according to a new report conducted by Grand View Research, Inc. The growing demand for electricity in developing countries including China, India, South Africa, and Brazil on account of increasing population and urbanization will drive the application of wind turbines. Furthermore, increasing government spending …
- 世界のバイオテクノロジー関連試薬市場:PCR試薬、細胞培養試薬、IVD試薬、クロマトグラフィー試薬などAbout Biotechnology Reagents Biotechnology reagents are chemical compounds or substances that are added to a system to detect and examine another substance to provide a test reading. Reagents are generally used in laboratories to prepare, collect, and examine specimens from the human body for specific diagnostics. Biotechnology reagents are used in the field of research, molecular biotechnology, h …
- 世界の細胞治療市場及びパイプラインインサイトResearch in cell therapy is transforming the future of medicine. As the life of a human being begins as a cell, these cells undergo a highly complex set of events and finally those few stem become capable of self-renewal and differentiation and develop into the specialized cells in the body. Cell therapy research also offers significant potential for restructuring the method of medical practice. S …
- ロシアの病院用品市場(~2021)Russia Hospital Supplies Market Outlook to 2021 - Disposable Hospital Supplies, Mobility Aids and Transportation Equipment, Operating Room Equipment, Patient Examination Devices, Sterilization Equipment and Syringes and Needles Summary GlobalData’s new report, "Russia Hospital Supplies Market Outlook to 2021 - Disposable Hospital Supplies, Mobility Aids and Transportation Equipment, Operating Room …
- Coastal Energy Company:石油・ガスの開発・生産動向及びコスト分析- Q1, 2013Coastal Energy Company Oil & Gas Exploration and Production Operations and Cost Analysis - Q1, 2013 Summary Coastal Energy Company Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential sour …
- 世界のEPDMシールストリップ市場2015< Global EPDM Sealing Strip Industry Report 2015> is a professional and deep research report on Global and China EPDM Sealing Strip industry. For overview analysis, the report introduces EPDM Sealing Strip basic information including definition, classification, application, industry chain structure, industry overview, policy analysis, and news analysis, etc. For international and China market anal …
- 自動車用運転シミュレーター世界市場2017-2021ABSTRACTAbout Automotive Driving Simulator Driving simulators, also called as sims, are a class of human-machine interfaces (HMIs), which are used to imitate the exact or near-exact conditions prevalent during driving, with respect to the driver's perspective, motion and physics perspective, as well as the vehicle interior and exterior perspective. Technavio’s analysts forecast the global automoti …
- 次世代シーケンシング(NGS)データ解析の世界市場分析:製品別(サービス、NGSコマーシャルソフトウェア、プラットフォームOS / UI、分析ソフトウェア、QC /前処理ツール、DNAシーケンシング、タンパク質シーケンシング、RNAシーケンシングアライメントツール)、ワークフロー別(第二次、第三、読み取りマッピング、呼び出し、検出、アプリケーション特有のデータ分析、標的化二亜硫酸塩、エクソーム、RNA配列決定、全ゲノム配列決定、チップ配列決定、経路分析)、エンドユーザー別、セグメント予測Global NGS data analysis market is anticipated to reach USD 2.03 billion by 2024, according to a new report by Grand View Research, Inc. Growth in next generation sequencing and data analysis market is driven by rise in adoption of laboratory management system (LIMS) in order to safeguard theobtained raw structure using downstream analyses. Demand for the data solutions that ensure provision of co …
- クロロプレンゴム(CR)の世界市場2015-2019About Chloroprene Rubber Chloroprene rubber (CR) is an artificial polymer, which acts as an elastomer. Elastomers can experience significantly greater elastic deformation under anxiety and recovers its previous size without permanent deformation. CR has great mechanical quality, high ozone and weather resistance, great aging resistance, low flammability, great resistance toward chemicals, moderate …
- スケール防止剤の世界市場:リン酸塩、カルボン酸塩、アクリル酸、スルホン酸The global antiscalant market size, in terms of value, is projected to reach USD 2.98 Billion by 2020, registering a CAGR of 4.73% between 2015 and 2020. In terms of volume, the market size is projected to reach 1,220.0 KT by 2020, registering a CAGR of 3.70% during the forecast period. The increasing demand of antiscalants from end-use industries such as oil & gas, power, mining, and water treatm …
- 自動車用トランスミッション液の世界市場2018-2022About Automotive Transmission Fluids Transmission fluid or oil is primarily used to lubricate the transmission components of a vehicle for its optimum performance. Technavio’s analysts forecast the Global Automotive Transmission Fluid Market to grow at a CAGR of 4.30% during the period 2018-2022. Covered in this report The report covers the present scenario and the growth prospects of the Global A …